OncoPrecision

We`re developing an assay to provide oncologists with a Drug Activity Ranking to aid them with cancer therapy selection based on available FDA-approved drugs. We`re using patient-derived cells to attempt to replicate the patient`s malignancy ex-vivo and test their tumorous cells with drugs and drug combinations to better understand their potential toxicity.